122 related articles for article (PubMed ID: 2091183)
21. Management of acute anemia in a Jehovah's Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin-based oxygen carrier: a case report and review of literature.
Donahue LL; Shapira I; Shander A; Kolitz J; Allen S; Greenburg G
Transfusion; 2010 Jul; 50(7):1561-7. PubMed ID: 20456679
[TBL] [Abstract][Full Text] [Related]
22. [Problems and therapy of acute lymphoblastic leukemia in children].
Matsuzaki A
Fukuoka Igaku Zasshi; 2000 Apr; 91(4):93-9. PubMed ID: 10917759
[No Abstract] [Full Text] [Related]
23. Acute lymphoblastic leukaemia therapy in Poland. A report from the Polish Children's Leukaemia/Lymphoma Study Group.
Radwańska U; Michalewska D; Armata J; Balwierz W; Bogusławska-Jaworska J; Cyklis R; Derulska D; Kołecki P; Lastowska M; Newecka-Samól T
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):199-210. PubMed ID: 2475398
[TBL] [Abstract][Full Text] [Related]
24. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol.
Suzuki N; Yumura-Yagi K; Yoshida M; Hara J; Nishimura S; Kudoh T; Tawa A; Usami I; Tanizawa A; Hori H; Ito Y; Miyaji R; Oda M; Kato K; Hamamoto K; Osugi Y; Hashii Y; Nakahata T; Horibe K;
Pediatr Blood Cancer; 2010 Jan; 54(1):71-8. PubMed ID: 19813250
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of acute lymphocytic leukemia].
Oshima T
Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):1046-52. PubMed ID: 1402253
[No Abstract] [Full Text] [Related]
26. Introduction of erythropoietin in the treatment of acute lymphoblastic leukemia (ALL) in a patient of Jehovah's Witnesses persuasion: a case report.
Blütters-Sawatzki R; Bertram U
Med Pediatr Oncol Suppl; 1992; 2():23-5. PubMed ID: 1306883
[No Abstract] [Full Text] [Related]
27. [Early deaths and intensification of the treatment of acute lymphoblastic leukemia in children].
Rytlewska M; Kubiczek K; Tretowska D
Pol Tyg Lek; 1988 Jul; 43(28):910-2. PubMed ID: 3247261
[No Abstract] [Full Text] [Related]
28. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
29. Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of and for the individual rather than the religious institution.
Elder L
Anesth Analg; 2007 Apr; 104(4):757-8. PubMed ID: 17377076
[No Abstract] [Full Text] [Related]
30. Adult acute leukemia.
Hoelzer D; Büchner T; Gale RP; Zittoun R
Rev Invest Clin; 1994 Apr; Suppl():21-5. PubMed ID: 7886303
[No Abstract] [Full Text] [Related]
31. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.
Horstmann MA; Hassenpflug WA; zur Stadt U; Escherich G; Janka G; Kabisch H
Haematologica; 2005 Dec; 90(12):1701-3. PubMed ID: 16330449
[TBL] [Abstract][Full Text] [Related]
32. [Blood transfusion and the Jehovah's Witnesses. A three-cushion game].
Gil JL
Sangre (Barc); 1999 Oct; 44(5):305-8. PubMed ID: 10618904
[No Abstract] [Full Text] [Related]
33. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
[TBL] [Abstract][Full Text] [Related]
34. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
35. [Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
Sato Y; Ito R; Saito T; Suto Y; Tateoka N; Onodera N; Ikeda Y; Ito E; Miyano T; Tachibana N
Rinsho Ketsueki; 1989 Nov; 30(11):1923-30. PubMed ID: 2607611
[TBL] [Abstract][Full Text] [Related]
36. Acute lymphoblastic leukaemia in a Jehovah's Witness: a management dilemma.
Zhou L; Mohsen A; Khan MA; Guthrie T
J Chemother; 2014 Jun; 26(3):184-6. PubMed ID: 24621157
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
38. [What we can learn from refusal of transfusion therapy from experience with Jehovah's Witnesses].
Vuk T; Putarek K; Jukić I; Rojnić N; Balija M; Grgicević D
Lijec Vjesn; 1997; 119(8-9):243-5. PubMed ID: 9481892
[TBL] [Abstract][Full Text] [Related]
39. What is blood and what is not? Caring for the Jehovah's Witness patient undergoing cardiac surgery.
Sniecinski R; Levy JH
Anesth Analg; 2007 Apr; 104(4):753-4. PubMed ID: 17377074
[No Abstract] [Full Text] [Related]
40. The role of peripheral blood stem cells as rescue after myeloablative therapy.
Reiffers J; Marit G; Boiron JM; Rice A; Bernard P; Vezon G
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():212-4. PubMed ID: 2565746
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
